Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
Evolent Health, Inc. (EVH)
|
Add to portfolio |
|
|
|
| Price: |
$27.96
| | Metrics |
| OS: |
111.1
|
M
| |
|
|
| Market cap: |
$3.11
|
B
| |
|
|
|
Net debt:
|
$490
|
M
| |
|
|
|
EV:
|
$3.6
|
B
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
|
| |
|
|
|
EBIT
|
|
| |
|
|
| EPS |
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 |
| Revenues | 1,352.0 | 908.0 | 924.6 | 687.1 | 627.1 | 435.0 | 254.2 | 96.9 |
| Revenue growth | 48.9% | -1.8% | 34.6% | 9.6% | 44.2% | 71.1% | 162.4% | |
| Cost of goods sold | 1,011.9 | 670.8 | 700.4 | 513.0 | 327.8 | 269.4 | 155.2 | 57.4 |
| Gross profit | 340.1 | 237.1 | 224.2 | 174.1 | 299.2 | 165.6 | 99.0 | 39.5 |
| Gross margin | 25.2% | 26.1% | 24.2% | 25.3% | 47.7% | 38.1% | 39.0% | 40.8% |
| Selling, general and administrative | 269.3 | 219.5 | 210.4 | 236.4 | 235.4 | 205.7 | 160.7 | 75.3 |
| EBITA | 45.6 | -0.7 | -0.8 | -95.0 | -29.1 | -51.4 | -67.2 | -65.3 |
| EBITA margin | 3.4% | -0.1% | -0.1% | -13.8% | -4.6% | -11.8% | -26.5% | -67.4% |
| Amortization of intangibles | 35.2 | 29.4 | 32.3 | 37.1 | 27.2 | 22.8 | 12.5 | 5.8 |
| EBIT | 10.4 | -30.1 | -33.2 | -132.1 | -56.3 | -74.2 | -79.7 | -71.1 |
| EBIT margin | 0.8% | -3.3% | -3.6% | -19.2% | -9.0% | -17.1% | -31.4% | -73.4% |
| Pre-tax income | -62.1 | -29.8 | -330.5 | -330.0 | -54.2 | -76.4 | -237.5 | 343.3 |
| Income taxes | -43.4 | 0.5 | -2.4 | -22.8 | 0.0 | -6.6 | -10.8 | 23.5 |
| Tax rate | 69.9% | | 0.7% | 6.9% | | 8.7% | 4.5% | 6.8% |
| Earnings from continuing ops | -19.2 | -37.6 | -334.2 | -303.6 | -52.7 | -60.7 | -159.7 | 330.3 |
| Earnings from discontinued ops | | 0.0 | 0.0 | 1.6 | | | | |
| Net income | -19.2 | -37.6 | -334.2 | -302.0 | -52.7 | -60.7 | -159.7 | 330.3 |
| Net margin | -1.4% | -4.1% | -36.1% | -43.9% | -8.4% | -13.9% | -62.8% | 341.0% |
| |
| Diluted EPS | ($0.20) | ($0.44) | ($3.94) | ($3.69) | ($0.68) | ($0.94) | ($3.55) | $7.16 |
| Shares outstanding (diluted) | 93.7 | 86.1 | 84.9 | 82.4 | 77.3 | 64.4 | 45.0 | 46.1 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|